Breast Cancer Trial, Recruiting NCT07500428 Sponsor: Peking Union Medical College Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07500428
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Breast ultrasound images (in standard grayscale format) sourced from a hospital imaging database or from publicly available research datasets that have documented ethics approval from their original institution
  • Images that are clear enough to be used for clinical diagnosis, with the area of interest visible
  • Cases where a confirmed tissue diagnosis exists (for images showing either a non-cancerous or cancerous finding), or where a specialist radiologist with more than 15 years of breast ultrasound experience has confirmed normal breast tissue (for the normal comparison group)
  • Images that have had all personal identifying information fully removed before being included

Who may not be able to join:

  • Images that are too poor in quality to allow a proper assessment using standard breast imaging reporting categories
  • Duplicate images from the same patient — only the single most representative image for each finding would be kept
  • Images where any personal identifying details remain after the removal process was carried out
  • Cases where the tissue diagnosis result is unclear, disputed among clinicians, or not available
  • Ultrasound images that are not in standard grayscale format, such as those using elastography, contrast-enhanced ultrasound, or Doppler techniques

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Qingli Zhu, MD, Peking Union Medical College Hospital

Phone: +86 13621376699

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 March 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic Accuracy for Pathological Diagnosis; BI-RADS Classification Accuracy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov